Search - tctmd.com

Displaying 21 - 34 of 34

Sort: Relevancy | Date

News Daily News

CV Risk Modest for Most Cancer Survivors in Large Danish Registry

L.A. McKeown

June 17, 2025

Presentation Fellows 2025

Pulmonary Embolism and Venous Disease: The Hottest Frontier of Endovascular Intervention

Presenter: S. Jay Mathews

May 18, 2025

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

L.A. McKeown

May 16, 2025

News Daily News

PFO, Risk Factors Both Exert Influence in Younger Cryptogenic Stroke Patients

Todd Neale

April 23, 2025

News Conference News EHRA 2025

Chronic HF Patients Needing CRT Fare Better With LBB Pacing: HeartSync-LBBP

Todd Neale

March 31, 2025

Presentation ACC 2025

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Presenter: Isabelle Mahé

March 29, 2025

News Conference News ACC 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Caitlin E. Cox

March 29, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Daily News

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

L.A. McKeown

March 06, 2025

News Daily News

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

L.A. McKeown

February 14, 2025

Presentation THT 2025

Safety and Feasibility of Renal Venous Afterload Modulation With the Doraya in Acute Decompensated Heart Failure and Persistent Congestion From Insufficient Response to Diuretic Therapy

Presenter: Lucas Zier

February 13, 2025

Presentation THT 2025

Safety and Efficacy of the preCARDIA System to Mechanically Reduce Cardiac Preload for Acutely Decompensated Heart Failure: The Expanded VENoUS Heart Failure (VENUS-HF) Early Feasibility Study

Presenter: Navin Kapur

February 12, 2025

News Conference News STS 2025

With Limited RCTs of Arterial Grafting, Researchers Take a Different Tack

Yael L. Maxwell

January 31, 2025

Presentation Miami Valves 2025

Transcatheter treatment of a sinus venosus ASD with partial anomalous pulmonary venous return

Presenter: Ignacio Inglessis-Azuaje

January 30, 2025

Advertisement

CV Risk Modest for Most Cancer Survivors in Large Danish Registry

Pulmonary Embolism and Venous Disease: The Hottest Frontier of Endovascular Intervention

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

PFO, Risk Factors Both Exert Influence in Younger Cryptogenic Stroke Patients

Chronic HF Patients Needing CRT Fare Better With LBB Pacing: HeartSync-LBBP

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

What’s Going to Be Hot at ACC 2025?

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

Safety and Feasibility of Renal Venous Afterload Modulation With the Doraya in Acute Decompensated Heart Failure and Persistent Congestion From Insufficient Response to Diuretic Therapy

Safety and Efficacy of the preCARDIA System to Mechanically Reduce Cardiac Preload for Acutely Decompensated Heart Failure: The Expanded VENoUS Heart Failure (VENUS-HF) Early Feasibility Study

With Limited RCTs of Arterial Grafting, Researchers Take a Different Tack

Transcatheter treatment of a sinus venosus ASD with partial anomalous pulmonary venous return

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content